SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences Group is seeing intense retail and institutional momentum driven by anticipation of the REGAL trial's final survival data, as shareholders watch for the announcement of the 80th patient event to trigger a potential buyout or market re-rating. The community is heavily focused on the squeeze potential created by high short interest and limited share availability, fueling widespread calls for a long-term hold ahead of expected clinical catalysts.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is experiencing significant market attention driven by a combination of heavy short interest and speculation regarding a potential short squeeze. Community discussion is split between traders targeting the low float for explosive upside and skeptics focused on the company's debt levels and operational challenges.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is trending due to heightened community debate surrounding a severe price drawdown, with bulls pointing to long-term industrial and investment demand as a floor while bears cite macro headwinds and potential retesting of historical support levels. Investors remain deeply divided, with many actively discussing whether to accumulate physical holdings at these lower levels or if the current technical breakdown signals a deeper, multi-year consolidation period.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market attention as traders debate whether the stock's current consolidation and recent technical breakout attempts signify an institutional accumulation phase or a prolonged downtrend. The community is actively discussing the company's long-term potential in AI-driven healthcare and oncology data analytics, weighing these fundamentals against high short interest and technical pressure.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors weigh a wave of strategic AI partnerships and defense-sector contract wins against persistent volatility and technical selling pressure. While the community is actively debating the company's long-term potential as an AI-native network infrastructure player, many remain focused on identifying a potential bottom ahead of upcoming earnings.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

ABVX is seeing high volatility as investors debate the impact of newly disclosed malignancy cases in the Phase 3 clinical trial against the drug's best-in-class efficacy data. The community is sharply divided, with bulls viewing the sell-off as a manipulative overreaction to noise and a prime buying opportunity, while others express concerns over potential regulatory hurdles like black box warnings.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is rallying sharply as investors react to the limited rollout of its latest FSD software update and renewed optimism surrounding its long-term robotics and autonomous driving ecosystem. While market participants are actively debating whether this momentum can hold or if it represents an overextended bull trap, the community is closely monitoring upcoming delivery figures as the key catalyst for the stock's next move.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened engagement as investors debate Cathie Wood's aggressive strategy of rotating out of established tech giants into speculative high-growth assets and space-related ventures. Community sentiment remains sharply divided, with discussions centered on long-term conviction versus frustration over the fund's recent performance compared to broader market benchmarks.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) remains a primary focal point as investors navigate significant market rotation, geopolitical tensions surrounding the Strait of Hormuz, and high-stakes Federal Reserve policy shifts. Market participants are actively debating whether the record-breaking performance of industrial and value-focused indices indicates underlying economic strength or a speculative bubble fueled by unsustainable AI-related capital expenditures.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is actively trending as investors weigh the potential impacts of a US-Iran memorandum of understanding on energy markets against the company's strong long-term fundamentals and growing LNG contract backlog. Community discussions are centered on whether the current volatility presents a buying opportunity, with many focusing on the gap between short-term geopolitical sentiment and the firm's capacity expansion and secure export revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Microcap MedTech Moving on U.S. Clinical Milestone

Advancements in diabetes technology continue to accelerate as companies race to improve patient outcomes and quality of life. Continuous glucose monitoring (CGM) has become one of the fastest-growing segments in healthcare, but limitations around wearable devices, sensor longevity, and accuracy still leave room for innovation. The next frontier may lie in implantable solutions designed to deliver more precise, real-time data without the burden of external hardware.Shares of Glucotrack, Inc. (NASDAQ: GCTK) are climbing sharply Friday morning after the company announced it is preparing to ...

AI, Biotech, and Biologics Drive Big Narratives

A new wave of healthcare innovation, powered by artificial intelligence, next-generation biologics, and shifting regulatory pathways, is colliding with market dynamics to create both breakthrough potential and high-volatility trading setups. $ARTL, $TGNT, $ADMA, $RCKT, $LTRN, $GCTK

GCTK Stock Is Soaring Today — What Is Fueling The Surge?

Equity

Glucotrack said it has achieved critical operational milestones in developing its continuous blood glucose monitoring technology.

Why Did Glucotrack Stock Surge 12% Pre-Market Today?

The company has received patents for its continuous blood glucose monitoring system.

Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update

Glucotrack announced a new financing arrangement with Sixth Borough Capital Fund LP on Thursday.


GlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s Why

GlucoTrack repurchased over 90% of its Series A warrants, while Sarepta disclosed a third patient death, suspended Elevidys shipments, and added a black-box warning amid FDA scrutiny.

Glucotrack Announces Positive Results From Its Implantable Blood Glucose Monitor Study: Retail Sentiment Hits 3-Month High

The company’s continuous blood glucose monitor demonstrated excellent accuracy, a 99% data capture rate, and no procedure or device-related serious adverse events, the company said.


Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.


This account has been verified as an official GCTK representative.

Verified Account

Glucotrack IR

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.312
Prev Close	$0.33
Open	$0.33
Dividend Yield	0.00%
50-Day Moving Average	$0.6141
Beta	1.35
Avg. Volume	5.93M
PE Ratio	-0.02

52-Week High	$14.14
52-Week Low	$0.2907
Market Capitalization	$2.07M
EPS (Annual)	-$31.22
Price to Book	-0.98
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

GCTKGlucoTrack Inc

Latest GCTK News